{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T19:44:29Z","timestamp":1792352669312,"version":"4.4.0"},"reference-count":133,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T00:00:00Z","timestamp":1555891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s11102-019-00960-0","type":"journal-article","created":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T11:03:21Z","timestamp":1555931001000},"page":"422-434","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":160,"title":["Non-functioning pituitary adenomas: indications for pituitary surgery and post-surgical management"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8993-2071","authenticated-orcid":false,"given":"Daniela","family":"Esposito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel S.","family":"Olsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oskar","family":"Ragnarsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Buchfelder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Skoglund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gudmundur","family":"Johannsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,22]]},"reference":[{"issue":"4","key":"960_CR1","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1530\/EJE-14-0144","volume":"171","author":"A Tjornstrand","year":"2014","unstructured":"Tjornstrand A, Gunnarsson K, Evert M, Holmberg E, Ragnarsson O, Rosen T, Filipsson Nystrom H (2014) The incidence rate of pituitary adenomas in western Sweden for the period 2001-2011. Eur J Endocrinol 171(4):519\u2013526. \n                    https:\/\/doi.org\/10.1530\/EJE-14-0144","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"960_CR2","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s11102-018-0869-3","volume":"21","author":"G Ntali","year":"2018","unstructured":"Ntali G, Wass JA (2018) Epidemiology, clinical presentation and diagnosis of non-functioning pituitary adenomas. Pituitary 21(2):111\u2013118. \n                    https:\/\/doi.org\/10.1007\/s11102-018-0869-3","journal-title":"Pituitary"},{"issue":"7","key":"960_CR3","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1210\/jc.2015-1475","volume":"100","author":"DS Olsson","year":"2015","unstructured":"Olsson DS, Nilsson AG, Bryngelsson IL, Trimpou P, Johannsson G, Andersson E (2015) Excess mortality in women and young adults with nonfunctioning pituitary adenoma: a swedish nationwide study. J Clin Endocrinol Metab 100(7):2651\u20132658. \n                    https:\/\/doi.org\/10.1210\/jc.2015-1475","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"960_CR4","doi-asserted-by":"publisher","first-page":"4268","DOI":"10.1210\/jc.2010-0537","volume":"95","author":"A Raappana","year":"2010","unstructured":"Raappana A, Koivukangas J, Ebeling T, Pirila T (2010) Incidence of pituitary adenomas in Northern Finland in 1992-2007. J Clin Endocrinol Metab 95(9):4268\u20134275. \n                    https:\/\/doi.org\/10.1210\/jc.2010-0537","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"960_CR5","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s11102-017-0855-1","volume":"21","author":"E Manojlovic-Gacic","year":"2018","unstructured":"Manojlovic-Gacic E, Engstrom BE, Casar-Borota O (2018) Histopathological classification of non-functioning pituitary neuroendocrine tumors. Pituitary 21(2):119\u2013129. \n                    https:\/\/doi.org\/10.1007\/s11102-017-0855-1","journal-title":"Pituitary"},{"issue":"3","key":"960_CR6","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/s12022-017-9498-z","volume":"28","author":"O Mete","year":"2017","unstructured":"Mete O, Lopes MB (2017) Overview of the 2017 WHO Classification of Pituitary Tumors. Endocr Pathol 28(3):228\u2013243. \n                    https:\/\/doi.org\/10.1007\/s12022-017-9498-z","journal-title":"Endocr Pathol"},{"issue":"1","key":"960_CR7","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s11060-010-0302-x","volume":"102","author":"L Chen","year":"2011","unstructured":"Chen L, White WL, Spetzler RF, Xu B (2011) A prospective study of nonfunctioning pituitary adenomas: presentation, management, and clinical outcome. J Neurooncol 102(1):129\u2013138. \n                    https:\/\/doi.org\/10.1007\/s11060-010-0302-x","journal-title":"J Neurooncol"},{"issue":"3","key":"960_CR8","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1210\/jc.2015-3653","volume":"101","author":"S Melmed","year":"2016","unstructured":"Melmed S (2016) Pituitary medicine from discovery to patient-focused outcomes. J Clin Endocrinol Metab 101(3):769\u2013777. \n                    https:\/\/doi.org\/10.1210\/jc.2015-3653","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"960_CR9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1530\/EJE-16-0173","volume":"175","author":"DS Olsson","year":"2016","unstructured":"Olsson DS, Bryngelsson IL, Ragnarsson O (2016) Higher incidence of morbidity in women than men with non-functioning pituitary adenoma: a Swedish nationwide study. Eur J Endocrinol 175(1):55\u201361. \n                    https:\/\/doi.org\/10.1530\/EJE-16-0173","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"960_CR10","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1530\/ERC-16-0518","volume":"24","author":"DS Olsson","year":"2017","unstructured":"Olsson DS, Hammarstrand C, Bryngelsson IL, Nilsson AG, Andersson E, Johannsson G, Ragnarsson O (2017) Incidence of malignant tumours in patients with a non-functioning pituitary adenoma. Endocr Relat Cancer 24(5):227\u2013235. \n                    https:\/\/doi.org\/10.1530\/ERC-16-0518","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"960_CR11","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1530\/eje.1.02334","volume":"156","author":"OM Dekkers","year":"2007","unstructured":"Dekkers OM, Hammer S, de Keizer RJ, Roelfsema F, Schutte PJ, Smit JW, Romijn JA, Pereira AM (2007) The natural course of non-functioning pituitary macroadenomas. Eur J Endocrinol 156(2):217\u2013224. \n                    https:\/\/doi.org\/10.1530\/eje.1.02334","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"960_CR12","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1210\/jcem.85.5.6611","volume":"85","author":"BM Arafah","year":"2000","unstructured":"Arafah BM, Prunty D, Ybarra J, Hlavin ML, Selman WR (2000) The dominant role of increased intrasellar pressure in the pathogenesis of hypopituitarism, hyperprolactinemia, and headaches in patients with pituitary adenomas. J Clin Endocrinol Metab 85(5):1789\u20131793. \n                    https:\/\/doi.org\/10.1210\/jcem.85.5.6611","journal-title":"J Clin Endocrinol Metab"},{"issue":"Pt 8","key":"960_CR13","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1093\/brain\/awh525","volume":"128","author":"MJ Levy","year":"2005","unstructured":"Levy MJ, Matharu MS, Meeran K, Powell M, Goadsby PJ (2005) The clinical characteristics of headache in patients with pituitary tumours. Brain 128(Pt 8):1921\u20131930. \n                    https:\/\/doi.org\/10.1093\/brain\/awh525","journal-title":"Brain"},{"issue":"1","key":"960_CR14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10194-008-0084-0","volume":"10","author":"JA Gondim","year":"2009","unstructured":"Gondim JA, de Almeida JP, de Albuquerque LA, Schops M, Gomes E, Ferraz T (2009) Headache associated with pituitary tumors. J Headache Pain 10(1):15\u201320. \n                    https:\/\/doi.org\/10.1007\/s10194-008-0084-0","journal-title":"J Headache Pain"},{"issue":"16","key":"960_CR15","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1177\/0333102412462639","volume":"32","author":"CJ Schankin","year":"2012","unstructured":"Schankin CJ, Reifferscheid AK, Krumbholz M, Linn J, Rachinger W, Langer S, Sostak P, Arzberger T, Kretzschmar H, Straube A (2012) Headache in patients with pituitary adenoma: clinical and paraclinical findings. Cephalalgia 32(16):1198\u20131207. \n                    https:\/\/doi.org\/10.1177\/0333102412462639","journal-title":"Cephalalgia"},{"issue":"10","key":"960_CR16","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1046\/j.1526-4610.1998.3810782.x","volume":"38","author":"T Abe","year":"1998","unstructured":"Abe T, Matsumoto K, Kuwazawa J, Toyoda I, Sasaki K (1998) Headache associated with pituitary adenomas. Headache 38(10):782\u2013786","journal-title":"Headache"},{"issue":"5","key":"960_CR17","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1001\/archneur.61.5.721","volume":"61","author":"MJ Levy","year":"2004","unstructured":"Levy MJ, Jager HR, Powell M, Matharu MS, Meeran K, Goadsby PJ (2004) Pituitary volume and headache: size is not everything. Arch Neurol 61(5):721\u2013725. \n                    https:\/\/doi.org\/10.1001\/archneur.61.5.721","journal-title":"Arch Neurol"},{"issue":"5","key":"960_CR18","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1001\/jama.2016.19699","volume":"317","author":"ME Molitch","year":"2017","unstructured":"Molitch ME (2017) Diagnosis and treatment of pituitary adenomas: a review. JAMA 317(5):516\u2013524. \n                    https:\/\/doi.org\/10.1001\/jama.2016.19699","journal-title":"JAMA"},{"issue":"5","key":"960_CR19","doi-asserted-by":"publisher","first-page":"W512","DOI":"10.2214\/AJR.15.14527","volume":"205","author":"IH Lee","year":"2015","unstructured":"Lee IH, Miller NR, Zan E, Tavares F, Blitz AM, Sung H, Yousem DM, Boland MV (2015) Visual defects in patients with pituitary adenomas: the myth of bitemporal hemianopsia. AJR Am J Roentgenol 205(5):W512\u2013W518. \n                    https:\/\/doi.org\/10.2214\/AJR.15.14527","journal-title":"AJR Am J Roentgenol"},{"issue":"5","key":"960_CR20","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s11102-017-0815-9","volume":"20","author":"IS Muskens","year":"2017","unstructured":"Muskens IS, Zamanipoor Najafabadi AH, Briceno V, Lamba N, Senders JT, van Furth WR, Verstegen MJT, Smith TRS, Mekary RA, Eenhorst CAE, Broekman MLD (2017) Visual outcomes after endoscopic endonasal pituitary adenoma resection: a systematic review and meta-analysis. Pituitary 20(5):539\u2013552. \n                    https:\/\/doi.org\/10.1007\/s11102-017-0815-9","journal-title":"Pituitary"},{"issue":"1","key":"960_CR21","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1210\/jcem.85.1.6309","volume":"85","author":"MR Drange","year":"2000","unstructured":"Drange MR, Fram NR, Herman-Bonert V, Melmed S (2000) Pituitary tumor registry: a novel clinical resource. J Clin Endocrinol Metab 85(1):168\u2013174. \n                    https:\/\/doi.org\/10.1210\/jcem.85.1.6309","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"960_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00701-003-0174-3","volume":"146","author":"P Nomikos","year":"2004","unstructured":"Nomikos P, Ladar C, Fahlbusch R, Buchfelder M (2004) Impact of primary surgery on pituitary function in patients with non-functioning pituitary adenomas\u2014a study on 721 patients. Acta Neurochir (Wien) 146(1):27\u201335. \n                    https:\/\/doi.org\/10.1007\/s00701-003-0174-3","journal-title":"Acta Neurochir (Wien)"},{"issue":"10","key":"960_CR23","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.1210\/jcem.84.10.6019","volume":"84","author":"SM Webb","year":"1999","unstructured":"Webb SM, Rigla M, Wagner A, Oliver B, Bartumeus F (1999) Recovery of hypopituitarism after neurosurgical treatment of pituitary adenomas. J Clin Endocrinol Metab 84(10):3696\u20133700. \n                    https:\/\/doi.org\/10.1210\/jcem.84.10.6019","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"960_CR24","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1210\/er.2015-1042","volume":"36","author":"C Briet","year":"2015","unstructured":"Briet C, Salenave S, Bonneville JF, Laws ER, Chanson P (2015) Pituitary apoplexy. Endocr Rev 36(6):622\u2013645. \n                    https:\/\/doi.org\/10.1210\/er.2015-1042","journal-title":"Endocr Rev"},{"issue":"1","key":"960_CR25","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11102-007-0018-x","volume":"10","author":"EH Nielsen","year":"2007","unstructured":"Nielsen EH, Lindholm J, Laurberg P, Bjerre P, Christiansen JS, Hagen C, Juul S, Jorgensen J, Kruse A, Stochholm K (2007) Nonfunctioning pituitary adenoma: incidence, causes of death and quality of life in relation to pituitary function. Pituitary 10(1):67\u201373. \n                    https:\/\/doi.org\/10.1007\/s11102-007-0018-x","journal-title":"Pituitary"},{"issue":"10","key":"960_CR26","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/j.jocn.2009.01.003","volume":"16","author":"F Zhang","year":"2009","unstructured":"Zhang F, Chen J, Lu Y, Ding X (2009) Manifestation, management and outcome of subclinical pituitary adenoma apoplexy. J Clin Neurosci 16(10):1273\u20131275. \n                    https:\/\/doi.org\/10.1016\/j.jocn.2009.01.003","journal-title":"J Clin Neurosci"},{"issue":"6","key":"960_CR27","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1111\/j.1365-2265.2004.02162.x","volume":"61","author":"J Ayuk","year":"2004","unstructured":"Ayuk J, McGregor EJ, Mitchell RD, Gittoes NJ (2004) Acute management of pituitary apoplexy\u2013surgery or conservative management? Clin Endocrinol 61(6):747\u2013752. \n                    https:\/\/doi.org\/10.1111\/j.1365-2265.2004.02162.x","journal-title":"Clin Endocrinol"},{"issue":"4","key":"960_CR28","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1210\/jc.2010-1048","volume":"96","author":"PU Freda","year":"2011","unstructured":"Freda PU, Beckers AM, Katznelson L, Molitch ME, Montori VM, Post KD, Vance ML (2011) Pituitary incidentaloma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 96(4):894\u2013904. \n                    https:\/\/doi.org\/10.1210\/jc.2010-1048","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"960_CR29","doi-asserted-by":"publisher","first-page":"E527","DOI":"10.1227\/NEU.0000000000001387","volume":"79","author":"M Fleseriu","year":"2016","unstructured":"Fleseriu M, Bodach ME, Tumialan LM, Bonert V, Oyesiku NM, Patil CG, Litvack Z, Aghi MK, Zada G (2016) Congress of neurological surgeons systematic review and evidence-based guideline for pretreatment endocrine evaluation of patients with nonfunctioning pituitary adenomas. Neurosurgery 79(4):E527\u2013E529. \n                    https:\/\/doi.org\/10.1227\/NEU.0000000000001387","journal-title":"Neurosurgery"},{"issue":"1","key":"960_CR30","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1590\/S0004-27302009000100006","volume":"53","author":"ML Cury","year":"2009","unstructured":"Cury ML, Fernandes JC, Machado HR, Elias LL, Moreira AC, Castro M (2009) Non-functioning pituitary adenomas: clinical feature, laboratorial and imaging assessment, therapeutic management and outcome. Arq Bras Endocrinol Metabol 53(1):31\u201339","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"5","key":"960_CR31","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1210\/jc.2005-2552","volume":"91","author":"OM Dekkers","year":"2006","unstructured":"Dekkers OM, Pereira AM, Roelfsema F, Voormolen JH, Neelis KJ, Schroijen MA, Smit JW, Romijn JA (2006) Observation alone after transsphenoidal surgery for nonfunctioning pituitary macroadenoma. J Clin Endocrinol Metab 91(5):1796\u20131801. \n                    https:\/\/doi.org\/10.1210\/jc.2005-2552","journal-title":"J Clin Endocrinol Metab"},{"key":"960_CR32","volume-title":"Endotext","author":"TT Chung","year":"2000","unstructured":"Chung TT, Monson JP (2000) Hypopituitarism. In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A (eds) Endotext. MDText.com, Inc., South Dartmouth"},{"issue":"5","key":"960_CR33","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1007\/s11102-017-0811-0","volume":"20","author":"D Esposito","year":"2017","unstructured":"Esposito D, Trimpou P, Giugliano D, Dehlin M, Ragnarsson O (2017) Pituitary dysfunction in granulomatosis with polyangiitis. Pituitary 20(5):594\u2013601. \n                    https:\/\/doi.org\/10.1007\/s11102-017-0811-0","journal-title":"Pituitary"},{"issue":"2","key":"960_CR34","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1159\/000336333","volume":"77","author":"N Iorgi Di","year":"2012","unstructured":"Di Iorgi N, Napoli F, Allegri AE, Olivieri I, Bertelli E, Gallizia A, Rossi A, Maghnie M (2012) Diabetes insipidus\u2013diagnosis and management. Horm Res Paediatr 77(2):69\u201384. \n                    https:\/\/doi.org\/10.1159\/000336333","journal-title":"Horm Res Paediatr"},{"issue":"2","key":"960_CR35","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.beem.2016.02.007","volume":"30","author":"GL Robertson","year":"2016","unstructured":"Robertson GL (2016) Diabetes insipidus: differential diagnosis and management. Best Pract Res Clin Endocrinol Metab 30(2):205\u2013218. \n                    https:\/\/doi.org\/10.1016\/j.beem.2016.02.007","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"2","key":"960_CR36","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1210\/jc.2010-1692","volume":"96","author":"S Melmed","year":"2011","unstructured":"Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA, Wass JA, Endocrine S (2011) Diagnosis and treatment of hyperprolactinemia: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 96(2):273\u2013288. \n                    https:\/\/doi.org\/10.1210\/jc.2010-1692","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"960_CR37","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s12020-009-9279-7","volume":"37","author":"JW Hong","year":"2010","unstructured":"Hong JW, Lee MK, Kim SH, Lee EJ (2010) Discrimination of prolactinoma from hyperprolactinemic non-functioning adenoma. Endocrine 37(1):140\u2013147. \n                    https:\/\/doi.org\/10.1007\/s12020-009-9279-7","journal-title":"Endocrine"},{"issue":"1","key":"960_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1148\/radiology.187.1.8451394","volume":"187","author":"AD Elster","year":"1993","unstructured":"Elster AD (1993) Modern imaging of the pituitary. Radiology 187(1):1\u201314. \n                    https:\/\/doi.org\/10.1148\/radiology.187.1.8451394","journal-title":"Radiology"},{"issue":"2","key":"960_CR39","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0720-048X(01)00412-0","volume":"41","author":"T Rand","year":"2002","unstructured":"Rand T, Lippitz P, Kink E, Huber H, Schneider B, Imhof H, Trattnig S (2002) Evaluation of pituitary microadenomas with dynamic MR imaging. Eur J Radiol 41(2):131\u2013135","journal-title":"Eur J Radiol"},{"issue":"4","key":"960_CR40","first-page":"610","volume":"33","author":"E Knosp","year":"1993","unstructured":"Knosp E, Steiner E, Kitz K, Matula C (1993) Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 33(4):610\u2013617 (Discussion 617\u2013618)","journal-title":"Neurosurgery"},{"issue":"4","key":"960_CR41","doi-asserted-by":"publisher","first-page":"803","DOI":"10.3171\/2014.12.JNS141083","volume":"122","author":"AS Micko","year":"2015","unstructured":"Micko AS, Wohrer A, Wolfsberger S, Knosp E (2015) Invasion of the cavernous sinus space in pituitary adenomas: endoscopic verification and its correlation with an MRI-based classification. J Neurosurg 122(4):803\u2013811. \n                    https:\/\/doi.org\/10.3171\/2014.12.JNS141083","journal-title":"J Neurosurg"},{"issue":"3","key":"960_CR42","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.ando.2015.04.006","volume":"76","author":"L Abouaf","year":"2015","unstructured":"Abouaf L, Vighetto A, Lebas M (2015) Neuro-ophthalmologic exploration in non-functioning pituitary adenoma. Ann Endocrinol 76(3):210\u2013219. \n                    https:\/\/doi.org\/10.1016\/j.ando.2015.04.006","journal-title":"Ann Endocrinol"},{"issue":"5","key":"960_CR43","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.beem.2009.05.001","volume":"23","author":"ME Molitch","year":"2009","unstructured":"Molitch ME (2009) Pituitary tumours: pituitary incidentalomas. Best Pract Res Clin Endocrinol Metab 23(5):667\u2013675. \n                    https:\/\/doi.org\/10.1016\/j.beem.2009.05.001","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"6","key":"960_CR44","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1017\/S0317167100051532","volume":"37","author":"WH Ryu","year":"2010","unstructured":"Ryu WH, Tam S, Rotenberg B, Labib MA, Lee D, Nicolle DA, Van Uum S, Duggal N (2010) Conservative management of pituitary macroadenoma contacting the optic apparatus. Can J Neurol Sci 37(6):837\u2013842","journal-title":"Can J Neurol Sci"},{"issue":"7","key":"960_CR45","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1210\/jc.2011-0251","volume":"96","author":"JS Loeffler","year":"2011","unstructured":"Loeffler JS, Shih HA (2011) Radiation therapy in the management of pituitary adenomas. J Clin Endocrinol Metab 96(7):1992\u20132003. \n                    https:\/\/doi.org\/10.1210\/jc.2011-0251","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"960_CR46","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1111\/j.1365-2265.2010.03875.x","volume":"73","author":"MH Murad","year":"2010","unstructured":"Murad MH, Fernandez-Balsells MM, Barwise A, Gallegos-Orozco JF, Paul A, Lane MA, Lampropulos JF, Natividad I, Perestelo-Perez L, Ponce de Leon-Lovaton PG, Albuquerque FN, Carey J, Erwin PJ, Montori VM (2010) Outcomes of surgical treatment for nonfunctioning pituitary adenomas: a systematic review and meta-analysis. Clin Endocrinol 73(6):777\u2013791. \n                    https:\/\/doi.org\/10.1111\/j.1365-2265.2010.03875.x","journal-title":"Clin Endocrinol"},{"issue":"4","key":"960_CR47","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/1097-0142(19910815)68:4<860::AID-CNCR2820680431>3.0.CO;2-4","volume":"68","author":"R Comtois","year":"1991","unstructured":"Comtois R, Beauregard H, Somma M, Serri O, Aris-Jilwan N, Hardy J (1991) The clinical and endocrine outcome to trans-sphenoidal microsurgery of nonsecreting pituitary adenomas. Cancer 68(4):860\u2013866","journal-title":"Cancer"},{"issue":"6","key":"960_CR48","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1055\/s-2004-820914","volume":"112","author":"M Wichers-Rother","year":"2004","unstructured":"Wichers-Rother M, Hoven S, Kristof RA, Bliesener N, Stoffel-Wagner B (2004) Non-functioning pituitary adenomas: endocrinological and clinical outcome after transsphenoidal and transcranial surgery. Exp Clin Endocrinol Diabetes 112(6):323\u2013327. \n                    https:\/\/doi.org\/10.1055\/s-2004-820914","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"4","key":"960_CR49","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1210\/jc.2010-1054","volume":"96","author":"MM Fernandez-Balsells","year":"2011","unstructured":"Fernandez-Balsells MM, Murad MH, Barwise A, Gallegos-Orozco JF, Paul A, Lane MA, Lampropulos JF, Natividad I, Perestelo-Perez L, Ponce de Leon-Lovaton PG, Erwin PJ, Carey J, Montori VM (2011) Natural history of nonfunctioning pituitary adenomas and incidentalomas: a systematic review and metaanalysis. J Clin Endocrinol Metab 96(4):905\u2013912. \n                    https:\/\/doi.org\/10.1210\/jc.2010-1054","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"960_CR50","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1530\/eje.0.1490123","volume":"149","author":"N Sanno","year":"2003","unstructured":"Sanno N, Oyama K, Tahara S, Teramoto A, Kato Y (2003) A survey of pituitary incidentaloma in Japan. Eur J Endocrinol 149(2):123\u2013127","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"960_CR51","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1111\/j.1365-2265.2007.02990.x","volume":"67","author":"N Karavitaki","year":"2007","unstructured":"Karavitaki N, Collison K, Halliday J, Byrne JV, Price P, Cudlip S, Wass JA (2007) What is the natural history of nonoperated nonfunctioning pituitary adenomas? Clin Endocrinol 67(6):938\u2013943. \n                    https:\/\/doi.org\/10.1111\/j.1365-2265.2007.02990.x","journal-title":"Clin Endocrinol"},{"issue":"10","key":"960_CR52","doi-asserted-by":"publisher","first-page":"3717","DOI":"10.1210\/jc.2008-0643","volume":"93","author":"OM Dekkers","year":"2008","unstructured":"Dekkers OM, Pereira AM, Romijn JA (2008) Treatment and follow-up of clinically nonfunctioning pituitary macroadenomas. J Clin Endocrinol Metab 93(10):3717\u20133726. \n                    https:\/\/doi.org\/10.1210\/jc.2008-0643","journal-title":"J Clin Endocrinol Metab"},{"issue":"20","key":"960_CR53","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.1001\/jama.1990.03440200076026","volume":"263","author":"M Reincke","year":"1990","unstructured":"Reincke M, Allolio B, Saeger W, Menzel J, Winkelmann W (1990) The \u2018incidentaloma\u2019 of the pituitary gland Is neurosurgery required? JAMA 263(20):2772\u20132776","journal-title":"JAMA"},{"issue":"1","key":"960_CR54","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ecl.2007.10.011","volume":"37","author":"ME Molitch","year":"2008","unstructured":"Molitch ME (2008) Nonfunctioning pituitary tumors and pituitary incidentalomas. Endocrinol Metab Clin North Am 37(1):151\u2013171. \n                    https:\/\/doi.org\/10.1016\/j.ecl.2007.10.011","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"6","key":"960_CR55","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1210\/jcem.87.6.8547","volume":"87","author":"WJ Inder","year":"2002","unstructured":"Inder WJ, Hunt PJ (2002) Glucocorticoid replacement in pituitary surgery: guidelines for perioperative assessment and management. J Clin Endocrinol Metab 87(6):2745\u20132750. \n                    https:\/\/doi.org\/10.1210\/jcem.87.6.8547","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"960_CR56","doi-asserted-by":"publisher","first-page":"3888","DOI":"10.1210\/jc.2016-2118","volume":"101","author":"M Fleseriu","year":"2016","unstructured":"Fleseriu M, Hashim IA, Karavitaki N, Melmed S, Murad MH, Salvatori R, Samuels MH (2016) Hormonal replacement in hypopituitarism in adults: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 101(11):3888\u20133921. \n                    https:\/\/doi.org\/10.1210\/jc.2016-2118","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"960_CR57","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1046\/j.1365-2265.1998.00555.x","volume":"49","author":"PM Clark","year":"1998","unstructured":"Clark PM, Neylon I, Raggatt PR, Sheppard MC, Stewart PM (1998) Defining the normal cortisol response to the short Synacthen test: implications for the investigation of hypothalamic-pituitary disorders. Clin Endocrinol 49(3):287\u2013292","journal-title":"Clin Endocrinol"},{"issue":"1","key":"960_CR58","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1046\/j.1365-2265.1997.d01-1748.x","volume":"46","author":"RJ Auchus","year":"1997","unstructured":"Auchus RJ, Shewbridge RK, Shepherd MD (1997) Which patients benefit from provocative adrenal testing after transsphenoidal pituitary surgery? Clin Endocrinol 46(1):21\u201327","journal-title":"Clin Endocrinol"},{"issue":"2","key":"960_CR59","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/0002-9343(84)90701-0","volume":"77","author":"PW Ladenson","year":"1984","unstructured":"Ladenson PW, Levin AA, Ridgway EC, Daniels GH (1984) Complications of surgery in hypothyroid patients. Am J Med 77(2):261\u2013266","journal-title":"Am J Med"},{"issue":"4","key":"960_CR60","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.wneu.2014.12.029","volume":"83","author":"E Divitiis de","year":"2015","unstructured":"de Divitiis E, Laws ER, Giani U, Iuliano SL, de Divitiis O, Apuzzo ML (2015) The current status of endoscopy in transsphenoidal surgery: an international survey. World Neurosurg 83(4):447\u2013454. \n                    https:\/\/doi.org\/10.1016\/j.wneu.2014.12.029","journal-title":"World Neurosurg"},{"issue":"3","key":"960_CR61","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1111\/jcmm.13445","volume":"22","author":"SY Yu","year":"2018","unstructured":"Yu SY, Du Q, Yao SY, Zhang KN, Wang J, Zhu Z, Jiang XB (2018) Outcomes of endoscopic and microscopic transsphenoidal surgery on non-functioning pituitary adenomas: a systematic review and meta-analysis. J Cell Mol Med 22(3):2023\u20132027. \n                    https:\/\/doi.org\/10.1111\/jcmm.13445","journal-title":"J Cell Mol Med"},{"issue":"5","key":"960_CR62","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1007\/s00701-017-3438-z","volume":"160","author":"RD Almutairi","year":"2018","unstructured":"Almutairi RD, Muskens IS, Cote DJ, Dijkman MD, Kavouridis VK, Crocker E, Ghazawi K, Broekman MLD, Smith TR, Mekary RA, Zaidi HA (2018) Gross total resection of pituitary adenomas after endoscopic vs. microscopic transsphenoidal surgery: a meta-analysis. Acta Neurochir 160(5):1005\u20131021. \n                    https:\/\/doi.org\/10.1007\/s00701-017-3438-z","journal-title":"Acta Neurochir"},{"issue":"2","key":"960_CR63","doi-asserted-by":"publisher","first-page":"346","DOI":"10.3171\/2013.9.JNS122207","volume":"120","author":"J Coburger","year":"2014","unstructured":"Coburger J, Konig R, Seitz K, Bazner U, Wirtz CR, Hlavac M (2014) Determining the utility of intraoperative magnetic resonance imaging for transsphenoidal surgery: a retrospective study. J Neurosurg 120(2):346\u2013356. \n                    https:\/\/doi.org\/10.3171\/2013.9.JNS122207","journal-title":"J Neurosurg"},{"issue":"5","key":"960_CR64","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.3171\/2014.6.JNS131994","volume":"121","author":"S Berkmann","year":"2014","unstructured":"Berkmann S, Schlaffer S, Nimsky C, Fahlbusch R, Buchfelder M (2014) Intraoperative high-field MRI for transsphenoidal reoperations of nonfunctioning pituitary adenoma. J Neurosurg 121(5):1166\u20131175. \n                    https:\/\/doi.org\/10.3171\/2014.6.JNS131994","journal-title":"J Neurosurg"},{"key":"960_CR65","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jocn.2016.10.044","volume":"37","author":"V Tandon","year":"2017","unstructured":"Tandon V, Raheja A, Suri A, Chandra PS, Kale SS, Kumar R, Garg A, Kalaivani M, Pandey RM, Sharma BS (2017) Randomized trial for superiority of high field strength intra-operative magnetic resonance imaging guided resection in pituitary surgery. J Clin Neurosci 37:96\u2013103. \n                    https:\/\/doi.org\/10.1016\/j.jocn.2016.10.044","journal-title":"J Clin Neurosci"},{"issue":"10","key":"960_CR66","doi-asserted-by":"publisher","first-page":"4709","DOI":"10.1210\/jc.2003-030461","volume":"88","author":"FG Barker 2nd","year":"2003","unstructured":"Barker FG 2nd, Klibanski A, Swearingen B (2003) Transsphenoidal surgery for pituitary tumors in the United States, 1996-2000: mortality, morbidity, and the effects of hospital and surgeon volume. J Clin Endocrinol Metab 88(10):4709\u20134719. \n                    https:\/\/doi.org\/10.1210\/jc.2003-030461","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"960_CR67","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.3171\/2012.2.JNS111837","volume":"116","author":"BJ Dlouhy","year":"2012","unstructured":"Dlouhy BJ, Madhavan K, Clinger JD, Reddy A, Dawson JD, O\u2019Brien EK, Chang E, Graham SM, Greenlee JD (2012) Elevated body mass index and risk of postoperative CSF leak following transsphenoidal surgery. J Neurosurg 116(6):1311\u20131317. \n                    https:\/\/doi.org\/10.3171\/2012.2.JNS111837","journal-title":"J Neurosurg"},{"issue":"4","key":"960_CR68","doi-asserted-by":"publisher","first-page":"303","DOI":"10.14639\/0392-100X-1086","volume":"37","author":"C Zhang","year":"2017","unstructured":"Zhang C, Ding X, Lu Y, Hu L, Hu G (2017) Cerebrospinal fluid rhinorrhoea following transsphenoidal surgery for pituitary adenoma: experience in a Chinese centre. Acta Otorhinolaryngol Ital 37(4):303\u2013307. \n                    https:\/\/doi.org\/10.14639\/0392-100X-1086","journal-title":"Acta Otorhinolaryngol Ital"},{"issue":"4","key":"960_CR69","doi-asserted-by":"publisher","first-page":"E541","DOI":"10.1227\/NEU.0000000000001392","volume":"79","author":"M Ziu","year":"2016","unstructured":"Ziu M, Dunn IF, Hess C, Fleseriu M, Bodach ME, Tumialan LM, Oyesiku NM, Patel KS, Wang R, Carter BS, Chen JY, Chen CC, Patil CG, Litvack Z, Zada G, Aghi MK (2016) Congress of neurological surgeons systematic review and evidence-based guideline on posttreatment follow-up evaluation of patients with nonfunctioning pituitary adenomas. Neurosurgery 79(4):E541\u2013E543. \n                    https:\/\/doi.org\/10.1227\/NEU.0000000000001392","journal-title":"Neurosurgery"},{"issue":"3","key":"960_CR70","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ando.2015.04.003","volume":"76","author":"C Cortet-Rudelli","year":"2015","unstructured":"Cortet-Rudelli C, Bonneville JF, Borson-Chazot F, Clavier L, Coche Dequeant B, Desailloud R, Maiter D, Rohmer V, Sadoul JL, Sonnet E, Toussaint P, Chanson P (2015) Post-surgical management of non-functioning pituitary adenoma. Ann Endocrinol 76(3):228\u2013238. \n                    https:\/\/doi.org\/10.1016\/j.ando.2015.04.003","journal-title":"Ann Endocrinol"},{"issue":"7","key":"960_CR71","doi-asserted-by":"publisher","first-page":"832","DOI":"10.4158\/EP14541.DSCR","volume":"21","author":"WW Woodmansee","year":"2015","unstructured":"Woodmansee WW, Carmichael J, Kelly D, Katznelson L (2015) American association of clinical endocrinologists and american college of endocrinology disease state clinical review: postoperative management following pituitary surgery. Endocr Pract 21(7):832\u2013838. \n                    https:\/\/doi.org\/10.4158\/EP14541.DSCR","journal-title":"Endocr Pract"},{"issue":"4","key":"960_CR72","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1210\/jc.2012-4059","volume":"98","author":"P Burman","year":"2013","unstructured":"Burman P, Mattsson AF, Johannsson G, Hoybye C, Holmer H, Dahlqvist P, Berinder K, Engstrom BE, Ekman B, Erfurth EM, Svensson J, Wahlberg J, Karlsson FA (2013) Deaths among adult patients with hypopituitarism: hypocortisolism during acute stress, and de novo malignant brain tumors contribute to an increased mortality. J Clin Endocrinol Metab 98(4):1466\u20131475. \n                    https:\/\/doi.org\/10.1210\/jc.2012-4059","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"960_CR73","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1023\/A:1022946220908","volume":"4","author":"JG Verbalis","year":"2003","unstructured":"Verbalis JG (2003) Diabetes insipidus. Rev Endocr Metab Disord 4(2):177\u2013185","journal-title":"Rev Endocr Metab Disord"},{"issue":"6","key":"960_CR74","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/ncpendmet0513","volume":"3","author":"JA Loh","year":"2007","unstructured":"Loh JA, Verbalis JG (2007) Diabetes insipidus as a complication after pituitary surgery. Nat Clin Pract Endocrinol Metab 3(6):489\u2013494. \n                    https:\/\/doi.org\/10.1038\/ncpendmet0513","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"1","key":"960_CR75","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11102-017-0843-5","volume":"21","author":"WT Burke","year":"2018","unstructured":"Burke WT, Cote DJ, Iuliano SI, Zaidi HA, Laws ER (2018) A practical method for prevention of readmission for symptomatic hyponatremia following transsphenoidal surgery. Pituitary 21(1):25\u201331. \n                    https:\/\/doi.org\/10.1007\/s11102-017-0843-5","journal-title":"Pituitary"},{"issue":"4","key":"960_CR76","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.3390\/jcm3041084","volume":"3","author":"MJ Hannon","year":"2014","unstructured":"Hannon MJ, Thompson CJ (2014) Neurosurgical Hyponatremia. J. Clin Med 3(4):1084\u20131104. \n                    https:\/\/doi.org\/10.3390\/jcm3041084","journal-title":"Clin Med"},{"issue":"4","key":"960_CR77","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1046\/j.1365-2265.1999.00666.x","volume":"50","author":"J Hensen","year":"1999","unstructured":"Hensen J, Henig A, Fahlbusch R, Meyer M, Boehnert M, Buchfelder M (1999) Prevalence, predictors and patterns of postoperative polyuria and hyponatraemia in the immediate course after transsphenoidal surgery for pituitary adenomas. Clin Endocrinol 50(4):431\u2013439","journal-title":"Clin Endocrinol"},{"issue":"6","key":"960_CR78","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1530\/EJE-14-0530","volume":"171","author":"J Matsuyama","year":"2014","unstructured":"Matsuyama J, Ikeda H, Sato S, Yamamoto K, Ohashi G, Watanabe K (2014) Early water intake restriction to prevent inappropriate antidiuretic hormone secretion following transsphenoidal surgery: low BMI predicts postoperative SIADH. Eur J Endocrinol 171(6):711\u2013716. \n                    https:\/\/doi.org\/10.1530\/EJE-14-0530","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"960_CR79","doi-asserted-by":"publisher","first-page":"448","DOI":"10.3171\/jns.2005.103.3.0448","volume":"103","author":"EC Nemergut","year":"2005","unstructured":"Nemergut EC, Zuo Z, Jane JA Jr, Laws ER Jr (2005) Predictors of diabetes insipidus after transsphenoidal surgery: a review of 881 patients. J Neurosurg 103(3):448\u2013454. \n                    https:\/\/doi.org\/10.3171\/jns.2005.103.3.0448","journal-title":"J Neurosurg"},{"issue":"5","key":"960_CR80","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1080\/02688690310001611233","volume":"17","author":"S Rajaratnam","year":"2003","unstructured":"Rajaratnam S, Seshadri MS, Chandy MJ, Rajshekhar V (2003) Hydrocortisone dose and postoperative diabetes insipidus in patients undergoing transsphenoidal pituitary surgery: a prospective randomized controlled study. Br J Neurosurg 17(5):437\u2013442","journal-title":"Br J Neurosurg"},{"issue":"4","key":"960_CR81","doi-asserted-by":"publisher","first-page":"414","DOI":"10.14310\/horm.2002.1762","volume":"16","author":"P Trimpou","year":"2017","unstructured":"Trimpou P, Olsson DS, Ehn O, Ragnarsson O (2017) Diagnostic value of the water deprivation test in the polyuria-polydipsia syndrome. Hormones 16(4):414\u2013422. \n                    https:\/\/doi.org\/10.14310\/horm.2002.1762","journal-title":"Hormones"},{"issue":"10","key":"960_CR82","doi-asserted-by":"publisher","first-page":"3426","DOI":"10.1210\/jc.2012-1981","volume":"97","author":"W Fenske","year":"2012","unstructured":"Fenske W, Allolio B (2012) Clinical review: current state and future perspectives in the diagnosis of diabetes insipidus: a clinical review. J Clin Endocrinol Metab 97(10):3426\u20133437. \n                    https:\/\/doi.org\/10.1210\/jc.2012-1981","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"960_CR83","doi-asserted-by":"publisher","first-page":"228","DOI":"10.7326\/0003-4819-103-2-228","volume":"103","author":"DW Richardson","year":"1985","unstructured":"Richardson DW, Robinson AG (1985) Desmopressin. Ann Intern Med 103(2):228\u2013239","journal-title":"Ann Intern Med"},{"issue":"3","key":"960_CR84","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s11102-010-0227-6","volume":"13","author":"NF Marko","year":"2010","unstructured":"Marko NF, Hamrahian AH, Weil RJ (2010) Immediate postoperative cortisol levels accurately predict postoperative hypothalamic-pituitary-adrenal axis function after transsphenoidal surgery for pituitary tumors. Pituitary 13(3):249\u2013255. \n                    https:\/\/doi.org\/10.1007\/s11102-010-0227-6","journal-title":"Pituitary"},{"issue":"2","key":"960_CR85","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1210\/jcem.79.2.8045946","volume":"79","author":"BM Arafah","year":"1994","unstructured":"Arafah BM, Kailani SH, Nekl KE, Gold RS, Selman WR (1994) Immediate recovery of pituitary function after transsphenoidal resection of pituitary macroadenomas. J Clin Endocrinol Metab 79(2):348\u2013354. \n                    https:\/\/doi.org\/10.1210\/jcem.79.2.8045946","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"960_CR86","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1210\/jcem-66-6-1208","volume":"66","author":"WM Hout","year":"1988","unstructured":"Hout WM, Arafah BM, Salazar R, Selman W (1988) Evaluation of the hypothalamic-pituitary-adrenal axis immediately after pituitary adenomectomy: is perioperative steroid therapy necessary? J Clin Endocrinol Metab 66(6):1208\u20131212. \n                    https:\/\/doi.org\/10.1210\/jcem-66-6-1208","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"960_CR87","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/BF03348813","volume":"15","author":"B Ambrosi","year":"1992","unstructured":"Ambrosi B, Bochicchio D, Peverelli S, Ferrario R, Faglia G (1992) Value of serum dehydroepiandrosterone sulfate assay in the evaluation of pituitary-adrenal insufficiency after pituitary adenomectomy. J Endocrinol Invest 15(11):827\u2013833. \n                    https:\/\/doi.org\/10.1007\/BF03348813","journal-title":"J Endocrinol Invest"},{"issue":"Pt 1","key":"960_CR88","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1177\/000456329403100108","volume":"31","author":"RS Jackson","year":"1994","unstructured":"Jackson RS, Carter GD, Wise PH, Alaghband-Zadeh J (1994) Comparison of paired short synacthen and insulin tolerance tests soon after pituitary surgery. Ann Clin Biochem 31(Pt 1):46\u201349. \n                    https:\/\/doi.org\/10.1177\/000456329403100108","journal-title":"Ann Clin Biochem"},{"issue":"4","key":"960_CR89","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1046\/j.1365-2265.2000.01106.x","volume":"53","author":"CH Courtney","year":"2000","unstructured":"Courtney CH, McAllister AS, McCance DR, Bell PM, Hadden DR, Leslie H, Sheridan B, Atkinson AB (2000) Comparison of one week 0900\u00a0h serum cortisol, low and standard dose synacthen tests with a 4 to 6\u00a0week insulin hypoglycaemia test after pituitary surgery in assessing HPA axis. Clin Endocrinol 53(4):431\u2013436","journal-title":"Clin Endocrinol"},{"issue":"10","key":"960_CR90","doi-asserted-by":"publisher","first-page":"3713","DOI":"10.1210\/jcem.85.10.6879","volume":"85","author":"HS Dokmetas","year":"2000","unstructured":"Dokmetas HS, Colak R, Kelestimur F, Selcuklu A, Unluhizarci K, Bayram F (2000) A comparison between the 1-microg adrenocorticotropin (ACTH) test, the short ACTH (250 microg) test, and the insulin tolerance test in the assessment of hypothalamo-pituitary-adrenal axis immediately after pituitary surgery. J Clin Endocrinol Metab 85(10):3713\u20133719. \n                    https:\/\/doi.org\/10.1210\/jcem.85.10.6879","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"960_CR91","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/j.1365-2265.2005.02368.x","volume":"63","author":"M Klose","year":"2005","unstructured":"Klose M, Lange M, Kosteljanetz M, Poulsgaard L, Feldt-Rasmussen U (2005) Adrenocortical insufficiency after pituitary surgery: an audit of the reliability of the conventional short synacthen test. Clin Endocrinol 63(5):499\u2013505. \n                    https:\/\/doi.org\/10.1111\/j.1365-2265.2005.02368.x","journal-title":"Clin Endocrinol"},{"issue":"2","key":"960_CR92","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1046\/j.1365-2265.1999.00773.x","volume":"51","author":"YJ Park","year":"1999","unstructured":"Park YJ, Park KS, Kim JH, Shin CS, Kim SY, Lee HK (1999) Reproducibility of the cortisol response to stimulation with the low dose (1 microg) of ACTH. Clin Endocrinol 51(2):153\u2013158","journal-title":"Clin Endocrinol"},{"issue":"10058","key":"960_CR93","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1016\/S0140-6736(16)30053-8","volume":"388","author":"CE Higham","year":"2016","unstructured":"Higham CE, Johannsson G, Shalet SM (2016) Hypopituitarism. Lancet 388(10058):2403\u20132415. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(16)30053-8","journal-title":"Hypopituitarism. Lancet"},{"issue":"2","key":"960_CR94","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/cen.13048","volume":"85","author":"V Munro","year":"2016","unstructured":"Munro V, Tugwell B, Doucette S, Clarke DB, Lacroix A, Imran SA (2016) Recovery of adrenal function after chronic secondary adrenal insufficiency in patients with hypopituitarism. Clin Endocrinol 85(2):216\u2013222. \n                    https:\/\/doi.org\/10.1111\/cen.13048","journal-title":"Clin Endocrinol"},{"issue":"1","key":"960_CR95","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/eje.0.1500001","volume":"150","author":"O Alexopoulou","year":"2004","unstructured":"Alexopoulou O, Beguin C, De Nayer P, Maiter D (2004) Clinical and hormonal characteristics of central hypothyroidism at diagnosis and during follow-up in adult patients. Eur J Endocrinol 150(1):1\u20138","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"960_CR96","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/clinchem\/42.1.155","volume":"42","author":"GG Klee","year":"1996","unstructured":"Klee GG (1996) Clinical usage recommendations and analytic performance goals for total and free triiodothyronine measurements. Clin Chem 42(1):155\u2013159","journal-title":"Clin Chem"},{"issue":"6","key":"960_CR97","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1210\/jcem-48-6-989","volume":"48","author":"G Faglia","year":"1979","unstructured":"Faglia G, Bitensky L, Pinchera A, Ferrari C, Paracchi A, Beck-Peccoz P, Ambrosi B, Spada A (1979) Thyrotropin secretion in patients with central hypothyroidism: evidence for reduced biological activity of immunoreactive thyrotropin. J Clin Endocrinol Metab 48(6):989\u2013998. \n                    https:\/\/doi.org\/10.1210\/jcem-48-6-989","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"960_CR98","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1111\/j.1365-2265.2011.03984.x","volume":"74","author":"O Koulouri","year":"2011","unstructured":"Koulouri O, Auldin MA, Agarwal R, Kieffer V, Robertson C, Falconer Smith J, Levy MJ, Howlett TA (2011) Diagnosis and treatment of hypothyroidism in TSH deficiency compared to primary thyroid disease: pituitary patients are at risk of under-replacement with levothyroxine. Clin Endocrinol 74(6):744\u2013749. \n                    https:\/\/doi.org\/10.1111\/j.1365-2265.2011.03984.x","journal-title":"Clin Endocrinol"},{"issue":"11","key":"960_CR99","doi-asserted-by":"publisher","first-page":"4144","DOI":"10.1210\/jc.2007-0941","volume":"92","author":"MR Martins","year":"2007","unstructured":"Martins MR, Doin FC, Komatsu WR, Barros-Neto TL, Moises VA, Abucham J (2007) Growth hormone replacement improves thyroxine biological effects: implications for management of central hypothyroidism. J Clin Endocrinol Metab 92(11):4144\u20134153. \n                    https:\/\/doi.org\/10.1210\/jc.2007-0941","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"960_CR100","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1507\/endocrj.43.307","volume":"43","author":"A Tominaga","year":"1996","unstructured":"Tominaga A, Uozumi T, Arita K, Kurisu K, Yano T, Hirohata T, Eguchi K, Iida K, Kawamoto H (1996) Effects of surgery on testosterone secretion in male patients with pituitary adenomas. Endocr J 43(3):307\u2013312","journal-title":"Endocr J"},{"issue":"6","key":"960_CR101","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1210\/jc.2009-2354","volume":"95","author":"S Bhasin","year":"2010","unstructured":"Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM, Task Force ES (2010) Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 95(6):2536\u20132559. \n                    https:\/\/doi.org\/10.1210\/jc.2009-2354","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"960_CR102","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1055\/s-0042-124355","volume":"125","author":"DM Monteiro","year":"2017","unstructured":"Monteiro DM, Freitas P, Vieira R, Carvalho D (2017) Hypogonadotropic hypogonadism in non-functioning pituitary adenomas: impact of intervention. Exp Clin Endocrinol Diabetes 125(6):368\u2013376. \n                    https:\/\/doi.org\/10.1055\/s-0042-124355","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"8","key":"960_CR103","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1507\/endocrj.EJ17-0536","volume":"65","author":"N Kobayashi","year":"2018","unstructured":"Kobayashi N, Yamaguchi-Okada M, Horiguchi K, Fukuhara N, Nishioka H, Yamada S (2018) Postoperative growth hormone dynamics in clinically nonfunctioning pituitary adenoma. Endocr J 65(8):827\u2013832. \n                    https:\/\/doi.org\/10.1507\/endocrj.EJ17-0536","journal-title":"Endocr J"},{"issue":"6","key":"960_CR104","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1210\/jc.2011-0179","volume":"96","author":"ME Molitch","year":"2011","unstructured":"Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Vance ML, Endocrine S (2011) Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96(6):1587\u20131609. \n                    https:\/\/doi.org\/10.1210\/jc.2011-0179","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"960_CR105","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1210\/jcem.87.5.8509","volume":"87","author":"BM Biller","year":"2002","unstructured":"Biller BM, Samuels MH, Zagar A, Cook DM, Arafah BM, Bonert V, Stavrou S, Kleinberg DL, Chipman JJ, Hartman ML (2002) Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency. J Clin Endocrinol Metab 87(5):2067\u20132079. \n                    https:\/\/doi.org\/10.1210\/jcem.87.5.8509","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"960_CR106","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1210\/jcem.83.5.4837","volume":"83","author":"G Aimaretti","year":"1998","unstructured":"Aimaretti G, Corneli G, Razzore P, Bellone S, Baffoni C, Arvat E, Camanni F, Ghigo E (1998) Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone\u2009+\u2009arginine as provocative tests for the diagnosis of GH deficiency in adults. J Clin Endocrinol Metab 83(5):1615\u20131618. \n                    https:\/\/doi.org\/10.1210\/jcem.83.5.4837","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"960_CR107","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1210\/jc.2018-00665","volume":"103","author":"JM Garcia","year":"2018","unstructured":"Garcia JM, Biller BMK, Korbonits M, Popovic V, Luger A, Strasburger CJ, Chanson P, Medic-Stojanoska M, Schopohl J, Zakrzewska A, Pekic S, Bolanowski M, Swerdloff R, Wang C, Blevins T, Marcelli M, Ammer N, Sachse R, Yuen KCJ (2018) Macimorelin as a diagnostic test for adult GH deficiency. J Clin Endocrinol Metab 103(8):3083\u20133093. \n                    https:\/\/doi.org\/10.1210\/jc.2018-00665","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"960_CR108","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1210\/jc.2013-1157","volume":"98","author":"JM Garcia","year":"2013","unstructured":"Garcia JM, Swerdloff R, Wang C, Kyle M, Kipnes M, Biller BM, Cook D, Yuen KC, Bonert V, Dobs A, Molitch ME, Merriam GR (2013) Macimorelin (AEZS-130)-stimulated growth hormone (GH) test: validation of a novel oral stimulation test for the diagnosis of adult GH deficiency. J Clin Endocrinol Metab 98(6):2422\u20132429. \n                    https:\/\/doi.org\/10.1210\/jc.2013-1157","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"960_CR109","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.3171\/2013.8.JNS13790","volume":"119","author":"S Berkmann","year":"2013","unstructured":"Berkmann S, Schlaffer S, Buchfelder M (2013) Tumor shrinkage after transsphenoidal surgery for nonfunctioning pituitary adenoma. J Neurosurg 119(6):1447\u20131452. \n                    https:\/\/doi.org\/10.3171\/2013.8.JNS13790","journal-title":"J Neurosurg"},{"issue":"5","key":"960_CR110","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s007010200064","volume":"144","author":"P Kremer","year":"2002","unstructured":"Kremer P, Forsting M, Ranaei G, Wuster C, Hamer J, Sartor K, Kunze S (2002) Magnetic resonance imaging after transsphenoidal surgery of clinically non-functional pituitary macroadenomas and its impact on detecting residual adenoma. Acta Neurochir 144(5):433\u2013443. \n                    https:\/\/doi.org\/10.1007\/s007010200064","journal-title":"Acta Neurochir"},{"issue":"5","key":"960_CR111","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.wneu.2014.07.014","volume":"82","author":"KS Patel","year":"2014","unstructured":"Patel KS, Kazam J, Tsiouris AJ, Anand VK, Schwartz TH (2014) Utility of early postoperative high-resolution volumetric magnetic resonance imaging after transsphenoidal pituitary tumor surgery. World Neurosurg 82(5):777\u2013780. \n                    https:\/\/doi.org\/10.1016\/j.wneu.2014.07.014","journal-title":"World Neurosurg"},{"issue":"1","key":"960_CR112","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s00701-013-1834-6","volume":"156","author":"DL Stofko","year":"2014","unstructured":"Stofko DL, Nickles T, Sun H, Dehdashti AR (2014) The value of immediate postoperative MR imaging following endoscopic endonasal pituitary surgery. Acta Neurochir 156(1):133\u2013140. \n                    https:\/\/doi.org\/10.1007\/s00701-013-1834-6\n                    \n                  \n                           (Discussion 140)","journal-title":"Acta Neurochir"},{"issue":"3","key":"960_CR113","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s10143-011-0365-y","volume":"35","author":"LR Barzaghi","year":"2012","unstructured":"Barzaghi LR, Medone M, Losa M, Bianchi S, Giovanelli M, Mortini P (2012) Prognostic factors of visual field improvement after trans-sphenoidal approach for pituitary macroadenomas: review of the literature and analysis by quantitative method. Neurosurg Rev 35(3):369\u2013378. \n                    https:\/\/doi.org\/10.1007\/s10143-011-0365-y\n                    \n                  \n                           (Discussion 378\u2013369)","journal-title":"Neurosurg Rev"},{"issue":"3","key":"960_CR114","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1136\/jnnp.2004.035576","volume":"76","author":"KK Gnanalingham","year":"2005","unstructured":"Gnanalingham KK, Bhattacharjee S, Pennington R, Ng J, Mendoza N (2005) The time course of visual field recovery following transphenoidal surgery for pituitary adenomas: predictive factors for a good outcome. J Neurol Neurosurg Psychiatry 76(3):415\u2013419. \n                    https:\/\/doi.org\/10.1136\/jnnp.2004.035576","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"960_CR115","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1007\/s00701-010-0654-1","volume":"152","author":"RA Kristof","year":"2010","unstructured":"Kristof RA, Kirchhofer D, Handzel D, Neuloh G, Schramm J, Mueller CA, Eter N (2010) Functional impairments caused by chiasma syndromes prior to and following transsphenoidal pituitary adenoma surgery. Acta Neurochir 152(8):1283\u20131290. \n                    https:\/\/doi.org\/10.1007\/s00701-010-0654-1","journal-title":"Acta Neurochir"},{"issue":"2","key":"960_CR116","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/j.1442-9071.1991.tb00637.x","volume":"19","author":"M Marcus","year":"1991","unstructured":"Marcus M, Vitale S, Calvert PC, Miller NR (1991) Visual parameters in patients with pituitary adenoma before and after transsphenoidal surgery. Aust N Z J Ophthalmol 19(2):111\u2013118","journal-title":"Aust N Z J Ophthalmol"},{"issue":"1","key":"960_CR117","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11102-007-0007-0","volume":"10","author":"OM Dekkers","year":"2007","unstructured":"Dekkers OM, de Keizer RJ, Roelfsema F, Vd Klaauw AA, Honkoop PJ, van Dulken H, Smit JW, Romijn JA, Pereira AM (2007) Progressive improvement of impaired visual acuity during the first year after transsphenoidal surgery for non-functioning pituitary macroadenoma. Pituitary 10(1):61\u201365. \n                    https:\/\/doi.org\/10.1007\/s11102-007-0007-0","journal-title":"Pituitary"},{"issue":"1","key":"960_CR118","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s11102-011-0347-7","volume":"15","author":"F Roelfsema","year":"2012","unstructured":"Roelfsema F, Biermasz NR, Pereira AM (2012) Clinical factors involved in the recurrence of pituitary adenomas after surgical remission: a structured review and meta-analysis. Pituitary 15(1):71\u201383. \n                    https:\/\/doi.org\/10.1007\/s11102-011-0347-7","journal-title":"Pituitary"},{"issue":"5","key":"960_CR119","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1530\/EJE-11-0566","volume":"165","author":"R Reddy","year":"2011","unstructured":"Reddy R, Cudlip S, Byrne JV, Karavitaki N, Wass JA (2011) Can we ever stop imaging in surgically treated and radiotherapy-naive patients with non-functioning pituitary adenoma? Eur J Endocrinol 165(5):739\u2013744. \n                    https:\/\/doi.org\/10.1530\/EJE-11-0566","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"960_CR120","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2016-4061","volume":"102","author":"M Tampourlou","year":"2017","unstructured":"Tampourlou M, Ntali G, Ahmed S, Arlt W, Ayuk J, Byrne JV, Chavda S, Cudlip S, Gittoes N, Grossman A, Mitchell R, O\u2019Reilly MW, Paluzzi A, Toogood A, Wass JAH, Karavitaki N (2017) Outcome of nonfunctioning pituitary adenomas that regrow after primary treatment: a study from two large UK centers. J Clin Endocrinol Metab 102(6):1889\u20131897. \n                    https:\/\/doi.org\/10.1210\/jc.2016-4061","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"960_CR121","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nrendo.2011.54","volume":"7","author":"JA Wass","year":"2011","unstructured":"Wass JA, Reddy R, Karavitaki N (2011) The postoperative monitoring of nonfunctioning pituitary adenomas. Nat Rev Endocrinol 7(7):431\u2013434. \n                    https:\/\/doi.org\/10.1038\/nrendo.2011.54","journal-title":"Nat Rev Endocrinol"},{"issue":"11","key":"960_CR122","doi-asserted-by":"publisher","first-page":"4406","DOI":"10.1210\/jc.2009-0471","volume":"94","author":"TW Noh","year":"2009","unstructured":"Noh TW, Jeong HJ, Lee MK, Kim TS, Kim SH, Lee EJ (2009) Predicting recurrence of nonfunctioning pituitary adenomas. J Clin Endocrinol Metab 94(11):4406\u20134413. \n                    https:\/\/doi.org\/10.1210\/jc.2009-0471","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"960_CR123","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.humpath.2007.10.004","volume":"39","author":"R Gejman","year":"2008","unstructured":"Gejman R, Swearingen B, Hedley-Whyte ET (2008) Role of Ki-67 proliferation index and p53 expression in predicting progression of pituitary adenomas. Hum Pathol 39(5):758\u2013766. \n                    https:\/\/doi.org\/10.1016\/j.humpath.2007.10.004","journal-title":"Hum Pathol"},{"issue":"9","key":"960_CR124","doi-asserted-by":"publisher","first-page":"3368","DOI":"10.1210\/jc.2017-00773","volume":"102","author":"G Raverot","year":"2017","unstructured":"Raverot G, Dantony E, Beauvy J, Vasiljevic A, Mikolasek S, Borson-Chazot F, Jouanneau E, Roy P, Trouillas J (2017) Risk of recurrence in pituitary neuroendocrine tumors: a prospective study using a five-tiered classification. J Clin Endocrinol Metab 102(9):3368\u20133374. \n                    https:\/\/doi.org\/10.1210\/jc.2017-00773","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"960_CR125","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14791\/btrt.2016.4.1.1","volume":"4","author":"MH Lee","year":"2016","unstructured":"Lee MH, Lee JH, Seol HJ, Lee JI, Kim JH, Kong DS, Nam DH (2016) Clinical concerns about recurrence of non-functioning pituitary adenoma. Brain Tumor Res Treat 4(1):1\u20137. \n                    https:\/\/doi.org\/10.14791\/btrt.2016.4.1.1","journal-title":"Brain Tumor Res Treat"},{"issue":"3","key":"960_CR126","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s10143-007-0072-x","volume":"30","author":"G Minniti","year":"2007","unstructured":"Minniti G, Jaffrain-Rea ML, Osti M, Cantore G, Enrici RM (2007) Radiotherapy for nonfunctioning pituitary adenomas: from conventional to modern stereotactic radiation techniques. Neurosurg Rev 30(3):167\u2013175. \n                    https:\/\/doi.org\/10.1007\/s10143-007-0072-x\n                    \n                  \n                           (Discussion 175\u2013166)","journal-title":"Neurosurg Rev"},{"issue":"4","key":"960_CR127","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1677\/ERC-08-0181","volume":"15","author":"A Colao","year":"2008","unstructured":"Colao A, Di Somma C, Pivonello R, Faggiano A, Lombardi G, Savastano S (2008) Medical therapy for clinically non-functioning pituitary adenomas. Endocr Relat Cancer 15(4):905\u2013915. \n                    https:\/\/doi.org\/10.1677\/ERC-08-0181","journal-title":"Endocr Relat Cancer"},{"key":"960_CR128","doi-asserted-by":"publisher","first-page":"469","DOI":"10.3389\/fendo.2018.00469","volume":"9","author":"O Cooper","year":"2018","unstructured":"Cooper O, Greenman Y (2018) Dopamine agonists for pituitary adenomas. Front Endocrinol 9:469. \n                    https:\/\/doi.org\/10.3389\/fendo.2018.00469","journal-title":"Front Endocrinol"},{"issue":"1","key":"960_CR129","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/eje-17-0796","volume":"178","author":"G Raverot","year":"2018","unstructured":"Raverot G, Burman P, McCormack A, Heaney A, Petersenn S, Popovic V, Trouillas J, Dekkers OM (2018) European society of endocrinology clinical practice guidelines for the management of aggressive pituitary tumours and carcinomas. Eur J Endocrinol 178(1):G1\u2013G24. \n                    https:\/\/doi.org\/10.1530\/eje-17-0796","journal-title":"Eur J Endocrinol"},{"key":"960_CR130","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.wneu.2016.09.092","volume":"97","author":"SM Priola","year":"2017","unstructured":"Priola SM, Esposito F, Cannavo S, Conti A, Abbritti RV, Barresi V, Baldari S, Ferrau F, Germano A, Tomasello F, Angileri FF (2017) Aggressive pituitary adenomas: the dark side of the moon. World Neurosurg 97:140\u2013155. \n                    https:\/\/doi.org\/10.1016\/j.wneu.2016.09.092","journal-title":"World Neurosurg"},{"issue":"4","key":"960_CR131","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1210\/jcem.85.4.6498","volume":"85","author":"B Nilsson","year":"2000","unstructured":"Nilsson B, Gustavasson-Kadaka E, Bengtsson BA, Jonsson B (2000) Pituitary adenomas in Sweden between 1958 and 1991: incidence, survival, and mortality. J Clin Endocrinol Metab 85(4):1420\u20131425. \n                    https:\/\/doi.org\/10.1210\/jcem.85.4.6498","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"960_CR132","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s11102-016-0764-8","volume":"20","author":"DS Olsson","year":"2017","unstructured":"Olsson DS, Bryngelsson IL, Ragnarsson O (2017) Time trends of mortality in patients with non-functioning pituitary adenoma: a Swedish nationwide study. Pituitary 20(2):218\u2013224. \n                    https:\/\/doi.org\/10.1007\/s11102-016-0764-8","journal-title":"Pituitary"},{"issue":"5","key":"960_CR133","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s11102-017-0838-2","volume":"20","author":"FF Casanueva","year":"2017","unstructured":"Casanueva FF, Barkan AL, Buchfelder M, Klibanski A, Laws ER, Loeffler JS, Melmed S, Mortini P, Wass J, Giustina A (2017) Criteria for the definition of pituitary tumor centers of excellence (PTCOE): a pituitary society statement. Pituitary 20(5):489\u2013498. \n                    https:\/\/doi.org\/10.1007\/s11102-017-0838-2","journal-title":"Pituitary"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-019-00960-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11102-019-00960-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-019-00960-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T19:14:47Z","timestamp":1587410087000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11102-019-00960-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,22]]},"references-count":133,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["960"],"URL":"https:\/\/doi.org\/10.1007\/s11102-019-00960-0","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,22]]},"assertion":[{"value":"22 April 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Daniela Esposito has received lecture fees from Ipsen. Daniel S. Olsson has been a consultant for Sandoz, Ipsen, and Pfizer. Michael Buchfelder is speaker for HRA Pharma, Ipsen, Novartis, and Pfizer, and has received funding from Novartis and Pfizer. Thomas Skoglund has received lecture fees from Abbott. Gudmundur Johannsson has received lecture fees from Novartis, Novo Nordisk, Pfizer, Sandoz, Merck Serono, and Otsuka as wells as consultancy fees from Astra Zeneca and Shire. Oskar Ragnarsson has nothing to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}